4-Substituted-7-N-alkyl-N-acetyl 2-aminobenzothiazole amides: Drug-like and non-xanthine based A2B adenosine receptor antagonists |
| |
Authors: | Adrian Wai-Hing Cheung John Brinkman Fariborz Firooznia Alexander Flohr Joseph Grimsby Mary Lou Gubler Kevin Guertin Rachid Hamid Nicholas Marcopulos Roger D Norcross Lida Qi Gwendolyn Ramsey Jenny Tan Yang Wen Ramakanth Sarabu |
| |
Institution: | 1. Roche Research Center, Hoffmann-La Roche Inc., Nutley, NJ 07110, USA;2. F. Hoffmann-La Roche Ltd, Pharma Research, CH-4070 Basel, Switzerland |
| |
Abstract: | 7-N-Acetamide-4-methoxy-2-aminobenzothiazole 4-fluorobenzamide (compound 1) was chosen as a drug-like and non-xanthine based starting point for the discovery of A2B receptor antagonists because of its slight selectivity against A1 and A2A receptors and modest A2B potency. SAR exploration of compound 1 described herein included modifications to the 7-N-acetamide group, substitution of the 4-methoxy group by halogens as well as replacement of the p-flouro-benzamide side chain. This work culminated in the identification of compound 37 with excellent A2B potency, modest selectivity versus A2A and A1 receptors, and good rodent PK properties. |
| |
Keywords: | |
本文献已被 ScienceDirect 等数据库收录! |
|